Live
- Pitroda remarks against Indian ethos: Dinakar
- Markapuram district possible only if NDA comes to power: Kandula
- INDIA bloc’s Eda Sudhakar Reddy files papers
- NRIs deny they held secret meeting
- Changed political equations favour TDP in Nellore City
- Modi errs, jittery EC sends notice to Nadda
- New Delhi: LG postpones MCD mayoral polls
- MyVoice: Views of our readers 26th April 2024
- Measuring scavenging value of vultures
- Celebrating 107 Years of Osmania University: A Legacy of Academic Excellence
Laurus Labs' Q2 net profit at Rs 57 crore
Laurus Labs Ltd on Friday announced that its total revenue grew by 21 per cent to Rs 712 crore against Rs 588 crore during Q2 FY' 19.
Hyderabad: Laurus Labs Ltd on Friday announced that its total revenue grew by 21 per cent to Rs 712 crore against Rs 588 crore during Q2 FY' 19.
The city-based drug-maker said, profit after tax (PAT) for the quarter ended September 30, 2019 was up by 249 per cent to Rs 56.6 crore against Rs 16.2 crore during the corresponding period last fiscal.
Satyanarayana Chava, CEO, Laurus Labs said, "the performance during the quarter shows the ability to execute the long-term strategy of the company with enhanced revenue from formulations business contributing positively to both topline and margins."
He further said: "We have recorded robust growth across most of our divisions.
The API (active pharmaceutical ingredient) division showed a strong growth during the quarter on the back of increase in new product additions, with oncology and synthesis maintaining their growth momentum."
